Do M&A create more value in the US than in Europe in the biotech and pharmaceutical sector ? An analysis of financial and innovation performances
Corman, Elise
Promotor(s) : Hübner, Georges
Date of defense : 2-Sep-2020/8-Sep-2020 • Permalink : http://hdl.handle.net/2268.2/10450
Details
Title : | Do M&A create more value in the US than in Europe in the biotech and pharmaceutical sector ? An analysis of financial and innovation performances |
Translated title : | [fr] Les M&A créent-elles plus de valeur aux Etats-Unis qu'en Europe dans le secteur pharmaceutique et des biotechs Une analyse des performances financières et en matière d'innovation? |
Author : | Corman, Elise |
Date of defense : | 2-Sep-2020/8-Sep-2020 |
Advisor(s) : | Hübner, Georges |
Committee's member(s) : | Streel, Alexandre
Lambert, Marie Mulier, Klaas |
Language : | English |
Number of pages : | 95 |
Keywords : | [en] innovation [en] Intellectual Capital [en] Tobin's Q [en] M&A |
Discipline(s) : | Business & economic sciences > Finance |
Institution(s) : | Université de Liège, Liège, Belgique |
Degree: | Master en ingénieur de gestion, à finalité spécialisée en Financial Engineering |
Faculty: | Master thesis of the HEC-Ecole de gestion de l'Université de Liège |
Abstract
[en] As the value of the M&A transactions tends to be higher in the US than in Europe, this work aims at assessing the real synergies resulting from those deals, on the financial and innovative aspects. This work focus will be on the Biotechnology and Pharmaceutical sector.
File(s)
Document(s)
Cite this master thesis
All documents available on MatheO are protected by copyright and subject to the usual rules for fair use.
The University of Liège does not guarantee the scientific quality of these students' works or the accuracy of all the information they contain.
The University of Liège does not guarantee the scientific quality of these students' works or the accuracy of all the information they contain.